arrow_back Back to App

Increasing Diversity in Alzheimer's Disease Research

This act aims to boost participation of ethnic and racial minorities in Alzheimer's disease clinical trials. This will lead to better tailored treatments and diagnostics for diverse populations, potentially improving the quality of life for many affected individuals.
Key points
New research centers will be established in minority-concentrated areas, improving access to studies.
Increased focus on educating and informing minorities about opportunities to participate in clinical trials.
Incentives for minority researchers to lead Alzheimer's disease studies.
Requirement for clinical trials to reflect patient diversity by removing unnecessary exclusion criteria.
article Official text account_balance Process page
Expired
Citizen Poll
No votes cast
Additional Information
Print number: 117_S_1548
Sponsor: Sen. Lujan, Ben Ray [D-NM]
Process start date: 2021-05-11
Lustra uses Artificial Intelligence. Verify details in source documents.
Summarized by: gemini-2.5-flash-preview-05-20
Source data: api.congress.gov
AI work logs for this document launch

OFFICIAL LEGAL TITLE

ENACT Act of 2021

FREQUENTLY ASKED QUESTIONS

What is the official ID of this bill?

The official print number for this legislation is 117_S_1548.

Which chamber initiated this legislation?

This legislation was initiated in the Senate.

When did the legislative process begin?

The process officially started on 2021-05-11.

What are the main provisions?

Key points include:

  • New research centers will be established in minority-concentrated areas, improving access to studies.
  • Increased focus on educating and informing minorities about opportunities to participate in clinical trials.
  • Incentives for minority researchers to lead Alzheimer's disease studies.
  • Requirement for clinical trials to reflect patient diversity by removing unnecessary exclusion criteria.
What is the specific legal status?

The current status is Expired.

Where can I read the full text of this legislation?

The full official text is available at: View full text

Who is the primary sponsor?

The primary sponsor is Sen. Lujan, Ben Ray [D-NM].

What is the latest detailed status?

The latest detailed status is: Introduced in Senate

Is this summary verified?

Yes. This content was analyzed by AI and verified by the Lustra Judge System on 2025-12-29.

CATEGORIES

Health